Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona
- 31 August 2009
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 59 (2) , 75-82
- https://doi.org/10.1016/j.jinf.2009.05.012
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Impact of Conjugate Vaccine on Transmission of Antimicrobial-Resistant Streptococcus pneumoniae Among Alaskan ChildrenThe Pediatric Infectious Disease Journal, 2008
- Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate VaccineClinical Infectious Diseases, 2008
- Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004The Journal of Infectious Diseases, 2007
- Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine CoverageJAMA, 2007
- Pre- and Postvaccination Clonal Compositions of Invasive Pneumococcal Serotypes for Isolates Collected in the United States in 1999, 2001, and 2002Journal of Clinical Microbiology, 2006
- Properties of Novel International Drug-Resistant Pneumococcal Clones Identified in Day-Care Centers of Lisbon, PortugalJournal of Clinical Microbiology, 2005
- Emergence of Penicillin‐NonsusceptibleStreptococcus pneumoniaeClones Expressing Serotypes Not Present in the Antipneumococcal Conjugate VaccineThe Journal of Infectious Diseases, 2004
- Postlicensure Surveillance for Pneumococcal Invasive Disease After Use of Heptavalent Pneumococcal Conjugate Vaccine in Northern California Kaiser PermanenteThe Pediatric Infectious Disease Journal, 2004
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part IClinical Infectious Diseases, 2000